Insights+: The US FDA New Drug Approvals in October 2022
November 17, 2022
Merck's Keytruda (pembrolizumab) Receives the US FDA's Approval as an Adjuvant Therapy for Renal Cell Carcinoma
November 19, 2021
Coherus and Junshi's Toripalimab Receive the US FDA's Orphan Drug Designation for the Treatment of Esophageal Cancer
November 16, 2021
Novartis' Scemblix (asciminib) Receives the US FDA's Approval for the Treatment of Chronic Myeloid Leukemia
October 29, 2021
Regeneron and Sanofi's Dupixent (dupilumab) Receive the US FDA's Approval as an Add-On Maintenance Treatment to Treat Moderate-To-...
October 21, 2021
Janssen Report Submission of sBLA to the US FDA for the Approval of Stelara (ustekinumab) to Treat Juvenile Psoriatic Arthritis
October 11, 2021
Back to Home
Incisive News in 3 Shots.
First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
Terms of Service
Copyright © 2023 PharmaShots - All Rights Reserved.